1-3 of 3
Barlogie Bart
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical and Molecular Characterization of Primary Plasma Cell Leukemia

Sandra Susanibar, MD, Pingping Qu, Antje Hoering, Sharmilan Thanendrarajan, MD, Jorge Jo Kamimoto, MD, Meera Mohan, MD, Pankaj Mathur, MD, Shadiqul Hoque, MD, Muthukumar Radhakrishnan, MD, Phil Farmer, Nathan Petty, Frits van Rhee, MD PhD, Maurizio Zangari, MD, Faith E. Davies, MD, Daisy Alapat, MD, Barlogie Bart, Gareth J. Morgan, MD PhD, Carolina D. Schinke, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3047.
https://doi.org/10.1182/blood.V130.Suppl_1.3047.3047
Published: 2017
Journal Articles

Biomarkers of Myeloma-Associated Lytic Bone Disease Using SELDI-TOF MS.

Bangzheng Chen, PhD, Hong Huixiao, Tong Weida, PhD, Walker Ronald, MD, Barlogie Bart, MD, PhD, Epstein Joshua, DSc
Journal: Blood
Blood (2004) 104 (11): 2463.
https://doi.org/10.1182/blood.V104.11.2463.2463
Published: 2004
Journal Articles

Comparable Survival in Newly Diagnosed Multiple Myeloma (MM) after VAD Induction with High Dose Therapy Using Melphalan 140mg/M 2 + TBI 12 Gy (MEL+TBI) Versus Standard Therapy with VBMCP and No Benefit from Interferon (IFN) Maintenance: Final Clinical Results of Intergroup Trial S9321 in the Context of IFM 90 and MRC VII Trials.

John Crowley, Rafael Fonseca, Phillip Greipp, McCoy Jason, Barlogie Bart
Journal: Blood
Blood (2004) 104 (11): 539.
https://doi.org/10.1182/blood.V104.11.539.539
Published: 2004